N-(3,4-dimethoxyphenyl)-N-((2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl)nitrous amide
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

N-(3,4-dimethoxyphenyl)-N-((2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl)nitrous amide

● In Stock

Catalogue No.:VE0022769
CAS No.:N/A
Mol. Formula:C15H16N2O7
Mol. Weight:336.30 g/mol

Additional information on N-(3 | 4-dimethoxyphenyl)-N-((2 | 2-dimethyl-4 | 6-dioxo-1 | 3-dioxan-5-ylidene)methyl)nitrous amide

Parent drug

Cabozantinib

IUPAC Name

N-(3, 4-dimethoxyphenyl)-N-((2, 2-dimethyl-4, 6-dioxo-1, 3-dioxan-5-ylidene)methyl)nitrous amide

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

COC1=CC=C(N(/C=C2C(OC(C)(C)OC/2=O)=O)N=O)C=C1OC

InChI

InChI=1S/C15H16N2O7/c1-15(2)23-13(18)10(14(19)24-15)8-17(16-20)9-5-6-11(21-3)12(7-9)22-4/h5-8H, 1-4H3

Description

The compound N-(3 | 4-dimethoxyphenyl)-N-((2 | 2-dimethyl-4 | 6-dioxo-1 | 3-dioxan-5-ylidene)methyl)nitrous amide is a thoroughly characterized reference standard that complies with rigorous regulatory guidelines | including those from USP | EMA | JP | and BP. It is ideal for critical applications such as analytical method development | method validation (AMV) | and quality control (QC) | especially in the production of Cabozantinib. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | this product delivers the precision required for reliable results. Additionally | it includes a detailed Structure Elucidation Report (SER) | ensuring accuracy and dependability for advanced analytical purposes.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url